Locations:
SearchAdvertisement
Genetic signature could help identify at-risk patients
Survival for months or several years while delaying treatment is possible
Learn about featured cancer clinical trials currently enrolling, or search our cancer clinical trials database for all open and accruing studies
Review assesses current data regarding treatment options
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Learn about featured cancer clinical trials currently enrolling, or search our cancer clinical trials database for all open and accruing studies
Learn about featured Cancer clinical trials currently enrolling, or search our Cancer clinical trials database for all open and accruing studies
Study suggests re-examining eligibility criteria for randomized controlled trials of hematologic malignancies.
Patient outcomes better with nanoparticle paclitaxel
Protocol changes can improve outcomes
More efficient, safer therapy may be on horizon
Advertisement
Advertisement